NCT02514603View on ClinicalTrials.gov

A Study of Prexasertib (LY2606368) in Japanese Participants With Advanced Cancers

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

April 10, 2017

Study Completion Date

April 10, 2017

Conditions
Neoplasm
Interventions
DRUG

Prexasertib

Administered IV

Trial Locations (2)

277 8577

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Chiba

104-0045

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Tokyo

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02514603 - A Study of Prexasertib (LY2606368) in Japanese Participants With Advanced Cancers | Biotech Hunter | Biotech Hunter